The effect of intravenous administration of cocarboxylase, of riboflavin, and of alloxazine mononucleotide (AMN) on the oxygen debt in heart patients.
D061605:Administration, Intravenous; D005415:Flavins; D006321:Heart; D006331:Heart Diseases / Q000378:metabolism*; D008660:Metabolism; D009711:Nucleotides / Q000494:pharmacology*; D010100:Oxygen; D012256:Riboflavin / Q000494:pharmacology*; D013835:Thiamine Pyrophosphate / Q000494:pharmacology*
D005415:Flavins; D009711:Nucleotides; C008173:isoalloxazine; D013835:Thiamine Pyrophosphate; D010100:Oxygen; D012256:Riboflavin
COCARBOXYLASE/effects; HEART DISEASE/metabolism in; METABOLISM; NUCLEOTIDES/effects; VITAMIN B2/effects